PROFILPELAJAR.COM

Ciprofibrate
Clinical data
AHFS/Drugs.com	International Drug Names
ATC code	C10AB08 (WHO) ;
Identifiers
	IUPAC name (RS)-2-[4-(2,2-dichlorocyclopropyl)phenoxy]-2-; methylpropanoic acid;
CAS Number	52214-84-3;
PubChem CID	2763;
IUPHAR/BPS	3438;
ChemSpider	2661 ;
UNII	F8252JGO9S;
KEGG	D03521 ;
ChEBI	CHEBI:50867 ;
ChEMBL	ChEMBL557555 ;
CompTox Dashboard (EPA)	DTXSID8020331 ;
ECHA InfoCard	100.052.478
Chemical and physical data
Formula	C13H14Cl2O3
Molar mass	289.15 g·mol−1
3D model (JSmol)	Interactive image;
Chirality	Racemic mixture
	SMILES ClC2(Cl)CC2c1ccc(OC(C(=O)O)(C)C)cc1;
	InChI InChI=1S/C13H14Cl2O3/c1-12(2,11(16)17)18-9-5-3-8(4-6-9)10-7-13(10,14)15/h3-6,10H,7H2,1-2H3,(H,16,17) ; Key:KPSRODZRAIWAKH-UHFFFAOYSA-N ;
	(verify)

Ciprofibrate is a fibrate that was developed as a lipid-lowering agent.

It was patented in 1972 and approved for medical use in 1985.^[1]

References

^ Fischer J, Ganellin CR (2006). Analogue-based Drug Discovery. John Wiley & Sons. p. 474. ISBN 9783527607495.

This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it.